Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
ConclusionIGF-1 is efficacious in improving sensory reactivity symptoms, repetitive behaviors, and hyperactivity in children with PMS.Trial registration NCT01525901.
Source: Molecular Autism - Category: Molecular Biology Source Type: research
More News: Autism | Child Development | Children | Clinical Trials | Genetics | Hyperactivity | Insulin | Molecular Biology | Statistics | Study